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Abstract
Infections with herpes simplex virus type 1 (HSV-1) are not
restricted to humans but infrequently may be transmitted to certain
animal species, in some cases resulting in severe disease, including
encephalitis and death. Recent studies demonstrate that human-
derived HSV-1 ﬁeld isolates can be typed according to their gG- gI-
and gE gene sequences. We investigated whether HSV-1 infections
of animals were predominantly caused by a certain genotype. Iso-
lates derived from two marmosets and one domestic rabbit, how-
ever, revealed different genotypes. Despite the very limited
number of investigated animal-derived HSV-1 strains, this result
does not point towards the existence of certain HSV-1 genotypes
with a higher potential of being transmitted to animals.
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The family Herpesviridae comprises a large family of DNA
viruses, which are divided according to their biological prop-
erties into three subfamilies: the Alpha-, Beta- and Gammaher-
pesvirinae [1]. Although phylogenetic data indicate a long-
standing co-evolution of herpesviruses with their hosts, there
is some residual potential to cross host species barriers [2].
Among zoonotic herpesviruses, Cercopithecine herpesvirus 1
(Herpes simiae, B virus) is the most signiﬁcant one and can
be transmitted from macaques to human beings, whereas,
the other way round, herpes simplex virus type 1 (HSV-1) =
Human herpesvirus 1 (HHV-1) can be transmitted occasion-
ally from humans to some (pet) animal species. A few other
herpesviruses (Saimiriine herpesvirus 2, Phocid herpesvirus 2,
Equid herpesvirus 1, Human herpesvirus 4, Gallid herpesvirus
2 and Suid herpesvirus 1) may have a limited or only sus-
pected ability to cross species barriers [3].
Regarding HSV-1, human-to-nonhuman zoonotic infections
have been reported for Old World primates, including goril-
las, chimpanzees, bonobos and white-handed gibbons, New
World monkeys, and prosimians. Although human-borne
HSV-1 infections of Old World primates remain localized
and cause only mild mucocutaneous lesions, New World
monkeys, including marmosets and tamarin species, and
prosimians are highly susceptible hosts for this zoonotic
infection, resulting in severe, often fatal disease [4–7]. Fur-
thermore, naturally occurring HSV-1 infections were also
observed in domestic rabbits, where this virus causes (usually
fatal) encephalitis [8–10]. Recently, classiﬁcation of clinical
human-derived HSV-1 isolates into different genotypes was
described, based on the nucleotide sequences of the three
glycoproteins G, I and E, which are located within the unique
short (US) region of the HSV-1 genome and are encoded by
the genes US4 (gG), US7 (gI) and US8 (gE), respectively
[11,12]. The present study aimed to investigate whether cer-
tain HSV-1 gG-, gI- or gE genotypes preferentially cause zoo-
notic infections of animals.
Two marmosets (Callithrix jacchus) and one domestic rab-
bit (Oryctolagus cuniculus), all having died from HSV-1 enceph-
alitis, were included in the study. All three cases were
independent of each other, and the marmosets originated
from different populations. Brain tissue homogenates of the
marmosets numbers 440/02 [6] and 766/07 (unpublished
data) (Fig. 1) were inoculated onto Vero cells. The cell cul-
tures were harvested when 80% of the cells exhibited a typi-
cal herpesvirus cytopathic effect, and the cell culture
supernatants were used for DNA extractions. The parafﬁn-
embedded brain tissue of domestic rabbit number T1634/05
was deparafﬁnized in xylene, washed in ethanol and digested
with proteinase K for 16 h. Viral DNA was extracted
employing the QIAamp Viral RNA Mini Kit (Qiagen, Hilden,
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Germany) according to the manufacturer’s protocol. Three
different primer pairs were used for the ampliﬁcation of the
gG gene [11], and the oligonucleotide primers for the ampli-
ﬁcation of the gI and gE gene are described elsewhere [12].
Two additional primer pairs were designed for the gI
gene (gI_1f: 5¢-ATGCCGTGCCGCCCGTTGCA-3¢; gI-289r:
5¢-ACGCGGTCACCGTGACGACA-3¢; gI_219f: 5¢-CGTAG
AGCTGTGGCACTACC-3¢; gI_574r: 5¢-GGCCGAATACG
GAAGCAGTT-3¢) and one for the gE gene (gE_323f: 5¢-GG
GGTCTACGAACGGACTTC-3¢; gE_690r: 5¢-GTCTCCAT
ACGCACGGTCAC-3¢) to overcome deﬁciencies in estab-
lishing the complete gene sequences. PCR was carried out
by employing a Fast Cycling PCR Kit 200 (Qiagen). Different
annealing temperatures were used for the ampliﬁcation of
the gG gene (55C), gI gene (58C) and gE gene (62C),
respectively. PCR products were prepared for sequencing on
both strands using BigDye Terminator, version 1.1, Cycle
Sequencing Kits (Applied Biosystems, Foster City, CA, USA)
and analysed on an automatic ABI Prism 310 genetic analyzer
(Perkin Elmer, Boston, MA, USA). The resulting DNA
sequences were aligned and compared with human isolates
collected in Sweden from Caucasians suffering from HSV-1
encephalitis, oral and genital lesions, respectively (GenBank
database). Phylogenetic trees were constructed, after boot-
strapping to 1000 replicates, by using the maximum-likeli-
hood method of the Mega4 software (http://
www.megasoftware.net/).
The HSV-1 glycoproteins G, I and E of two marmosets
and one domestic rabbit were completely sequenced, and
the sequences were deposited in GenBank under the acces-
sion numbers GQ898899–GQ898901. In the phylogenetic
analysis, which included the animal-derived HSV-1 sequences
determined in the present study as well as representative
human-derived HSV-1 ﬁeld strains, each of these three gly-
coproteins were separated into three main genetic groups
A–C (Fig. 2). Glycoprotein G constitutes a part of the viral
envelope and is important for virus entry through apical
surfaces of polarized epithelial cells [13]. The gG gene com-
passes 717 nucleotides and consists of a ﬁrst conserved
part (nucleotides 1–234) and a second part (nucleotides
256–717) containing 18 speciﬁc sites responsible for dis-
crimination into genotypes A, B and C [12]. Nucleotide
sequence alignments of the gG gene revealed no other
nucleotide exchanges beside that at the genotype-speciﬁc
positions. The glycoproteins I and E (US7 and US8) form a
heterooligomer that is required for efﬁcient neurone-to-
neurone transmission through synaptically linked neuronal
pathways [14]. Sequence alignments of the gI gene showed
one A to C transversion at nucleotide 800 that results in
an amino acid exchange of Y to S at site 288 in the case of
the rabbit. Furthermore, one amino acid substitution could
also be observed in the gE sequence alignments showing a
G to V amino acid exchange at position 8 in the signal pep-
tide region of marmoset 766/07. Whether both amino acid
substitutions inﬂuence the structure or functions of the
individual proteins requires further investigation. No amino
acid exchanges were observed at potential N-linked glyco-
sylation sites of gG, gI and gE in the three samples. Phylo-
genetic analysis of the gG and gI sequences clustered the
marmoset 440/02-derived HSV-1 into genotype A, whereas
the HSV-1 isolated from marmoset 766/07 and rabbit
T1634/05 clustered within genotype B. However, when the
gE sequences were analysed, the marmoset 766/07-derived
HSV-1 did not cluster within any of the known genotypes
(indicated non A/B/C; Fig. 2, Table 1). Considering that a
great number of clinical HSV-1 isolates are intergenic rec-
ombinants with recombination points located between the
respective genes, this suggests that the marmoset 766/07-
derived HSV-1 might resemble a recombinant [12,15,16]
with a so far unknown HSV-1 gE genotype. A 10-year
molecular survey of clinical human HSV-1 isolates in
Germany revealed a high prevalence of genotypes A and B
[16]; thus, it is not surprising that the three animal-derived
HSV-1 also belong to genogroups A and B, respectively
(with the exception of the gE sequence of marmoset isolate
FIG. 1. Marmoset number 766/07 with facial lesions; a few days
later, it died as a result of herpes simplex virus type 1 encephalitis
despite antiherpesviral therapy.
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766/07). HSV-1 infections in animals are extremely rare;
therefore, we were able to investigate these three cases
within a time span of 5 years only. We are well aware that
no deﬁnite conclusions can be made based on such a small
number of cases; nonetheless, our results do not point
towards the existence of certain HSV-1 genotypes that have
a higher potential of crossing the species barrier and being
transmitted to animals. More animal HSV-1 cases need to
be investigated genetically to verify or falsify our preliminary
conclusion.
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Abstract
In this study, the serological status of the southern Greek popu-
lation in the 1–10-year, 11–20-year, 21–30-year and 31–40-year
age groups with regard to Sabin vaccine strains and a collection
of 15 recombinant and four non-recombinant poliovirus vaccine
strains was determined. For all three poliovirus types, the high-
est neutralization test (NT) titres were observed in the 1–10-
year age group, indicating a good response to vaccination. In
general, the serological status of the population of southern
Greece with regard to poliovirus is better for types 1 and 2
than for type 3. The presence of the lowest NT titre in the 21–
30-year age group against poliovirus type 3 suggests the need
for a booster dose of monovalent Sabin3 vaccine to ensure per-
sonal and herd immunity.
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Since the 1960s, poliovirus, the causal agent of poliomyelitis,
has been effectively controlled by the use of inactivated
poliovirus vaccine (IPV) or live attenuated oral poliovirus
vaccine (OPV), which is composed of attenuated strains of
each of the three serotypes (Sabin1, Sabin2, and Sabin3) [1].
By 1964, OPV was the vaccine that had been adopted
throughout most of the world, because of several advantages
over IPV, such as: simplicity of administration, induction of
mucosal immunity and neutralizing antibodies, and low cost.
Since the Poliomyelitis Eradication Initiative was launched in
1988, great progress has been made in stopping the trans-
mission of wild-type poliovirus and in achieving global certiﬁ-
cation of eradication by 2005 [2]. The number of
poliomyelitis cases due to infections with wild-type polio-
viruses decreased from an estimated 350 000 in over 125
endemic countries in 1988 to just 1310 in four countries in
2007 [3]. Poliomyelitis transmission has been interrupted in
the American, European and Western Paciﬁc regions, and by
the end of 2002 more than 180 countries and territories had
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